KALION, INC.
Milton, MA · Founded 2010 · CIK 0001595918 · Biotech · Private
Genetically engineered E. coli strains and fermentation process for biobased production of glucaric acid from glucose
kalioninc.com →- Grants
- $1.2M
- 3 awards
- Sector median: 1
- Raised
- $6.7M
- 7 Form D · Nov 2023
- 35 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201320152017201920212023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $747,308 | |
| Private capital raised | Form D · SEC | $697,224 | |
| Federal grant | National Science Foundation · Phase I · STTR Phase I: Bioprocess-derived Glucaric Acid as a Renewable Feedstock for Diverse Polymers | $225,000 | |
| Private capital raised | Form D · SEC | $519,015 | |
| Federal grant | National Science Foundation · Phase I · STTR Phase I: Low-Cost, High-Purity Biobased Glucaric Acid | $225,000 | |
| Private capital raised | Form D · SEC | $2,999,970 | |
| Federal grant | National Science Foundation · Phase II · SBIR Phase II: Low-Cost, High-Purity Biobased Glucaric Acid | $746,822 | |
| Private capital raised | Form D · SEC | $700,445 | |
| Private capital raised | Form D · SEC | $640,804 | |
| Private capital raised | Form D · SEC | $405,869 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2144 | Scinai Immunotherapeutics Ltd. | — | $3.0M |
| 2145 | ISOLERE BIO INC | — | — |
| 2146 | Origin Life Sciences, Inc. | — | $2.9M |
| 2147 | KALION, INC. | — | $6.7M |
| 2148 | VIRONGY, LLC | — | — |
| 2149 | EpiBiologics, Inc. | — | $30M |
| 2150 | Egalet Corp | — | $42M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Nada JainDirector
- Kristala Jones PratherDirector
- Melissa KentDirector
- Robert MiniuttiDirector
- Darcy PratherDirector · Executive Officer
- Kristala PratherDirector · Executive Officer
- Andrew ShaferDirector
- Joan ZiefDirector
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.